| Peggie Ann Bensch, MD | |
|
1055 N Curtis Rd, Boise, ID 83706-1309 | |
| (208) 367-7350 | |
| Not Available |
| Full Name | Peggie Ann Bensch |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 27 Years |
| Location | 1055 N Curtis Rd, Boise, Idaho |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164468187 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD00037723 (Washington) | Secondary |
| 207R00000X | Internal Medicine | M-11715 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Olympic Medical Center | Port angeles, WA | Hospital |
| Saint Alphonsus Regional Medical Center | Boise, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Saint Alphonsus Regional Medical Center Inc | 3476462359 | 509 |
| Olympic Medical Physicians | 9537172358 | 113 |
News Archive
A team of scientists from Boston University School of Medicine (BUSM) have identified a novel compound that inhibits viruses from replicating. The findings, which are published online in the Journal of Virology, could lead to the development of highly targeted compounds to block the replication of poxviruses, such as the emerging infectious disease Monkeypox.
DaVita HealthCare Partners Inc., one of the largest and most innovative health care communities, today announced the company has expanded its office space to include two more floors of the Gates Building, located at 1551 Wewatta Street in Lower Downtown Denver.
Vanda Pharmaceuticals has announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for iloperidone, an investigational atypical antipsychotic for the treatment of schizophrenia.
The proportion of poor adults age 40 and over with diabetes who had their blood sugar, eyes and feet examined at least once a year dropped from 39 percent to 23 percent between 2002 and 2007, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
The European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI) and the Biotechnology and Biological Sciences Research Council (BBSRC) warmly welcome today's announcement from the UK Government of a £75 million commitment from the Department for Business, Innovation and Skills' Large Facilities Capital Fund (LFCF) for the ELIXIR research infrastructure.
› Verified 4 days ago
| Entity Name | Saint Alphonsus Regional Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649357716 PECOS PAC ID: 3476462359 Enrollment ID: O20040204001036 |
News Archive
A team of scientists from Boston University School of Medicine (BUSM) have identified a novel compound that inhibits viruses from replicating. The findings, which are published online in the Journal of Virology, could lead to the development of highly targeted compounds to block the replication of poxviruses, such as the emerging infectious disease Monkeypox.
DaVita HealthCare Partners Inc., one of the largest and most innovative health care communities, today announced the company has expanded its office space to include two more floors of the Gates Building, located at 1551 Wewatta Street in Lower Downtown Denver.
Vanda Pharmaceuticals has announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for iloperidone, an investigational atypical antipsychotic for the treatment of schizophrenia.
The proportion of poor adults age 40 and over with diabetes who had their blood sugar, eyes and feet examined at least once a year dropped from 39 percent to 23 percent between 2002 and 2007, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
The European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI) and the Biotechnology and Biological Sciences Research Council (BBSRC) warmly welcome today's announcement from the UK Government of a £75 million commitment from the Department for Business, Innovation and Skills' Large Facilities Capital Fund (LFCF) for the ELIXIR research infrastructure.
› Verified 4 days ago
| Entity Name | Sound Physicians Of Idaho |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730407461 PECOS PAC ID: 4688705346 Enrollment ID: O20100624000921 |
News Archive
A team of scientists from Boston University School of Medicine (BUSM) have identified a novel compound that inhibits viruses from replicating. The findings, which are published online in the Journal of Virology, could lead to the development of highly targeted compounds to block the replication of poxviruses, such as the emerging infectious disease Monkeypox.
DaVita HealthCare Partners Inc., one of the largest and most innovative health care communities, today announced the company has expanded its office space to include two more floors of the Gates Building, located at 1551 Wewatta Street in Lower Downtown Denver.
Vanda Pharmaceuticals has announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for iloperidone, an investigational atypical antipsychotic for the treatment of schizophrenia.
The proportion of poor adults age 40 and over with diabetes who had their blood sugar, eyes and feet examined at least once a year dropped from 39 percent to 23 percent between 2002 and 2007, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
The European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI) and the Biotechnology and Biological Sciences Research Council (BBSRC) warmly welcome today's announcement from the UK Government of a £75 million commitment from the Department for Business, Innovation and Skills' Large Facilities Capital Fund (LFCF) for the ELIXIR research infrastructure.
› Verified 4 days ago
| Entity Name | Hospitalist Medicine Physicians Of Idaho- Nampa Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558995316 PECOS PAC ID: 2365871688 Enrollment ID: O20200407001850 |
News Archive
A team of scientists from Boston University School of Medicine (BUSM) have identified a novel compound that inhibits viruses from replicating. The findings, which are published online in the Journal of Virology, could lead to the development of highly targeted compounds to block the replication of poxviruses, such as the emerging infectious disease Monkeypox.
DaVita HealthCare Partners Inc., one of the largest and most innovative health care communities, today announced the company has expanded its office space to include two more floors of the Gates Building, located at 1551 Wewatta Street in Lower Downtown Denver.
Vanda Pharmaceuticals has announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for iloperidone, an investigational atypical antipsychotic for the treatment of schizophrenia.
The proportion of poor adults age 40 and over with diabetes who had their blood sugar, eyes and feet examined at least once a year dropped from 39 percent to 23 percent between 2002 and 2007, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
The European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI) and the Biotechnology and Biological Sciences Research Council (BBSRC) warmly welcome today's announcement from the UK Government of a £75 million commitment from the Department for Business, Innovation and Skills' Large Facilities Capital Fund (LFCF) for the ELIXIR research infrastructure.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peggie Ann Bensch, MD 1055 N Curtis Rd, Boise, ID 83706-1309 Ph: (208) 367-2121 | Peggie Ann Bensch, MD 1055 N Curtis Rd, Boise, ID 83706-1309 Ph: (208) 367-7350 |
News Archive
A team of scientists from Boston University School of Medicine (BUSM) have identified a novel compound that inhibits viruses from replicating. The findings, which are published online in the Journal of Virology, could lead to the development of highly targeted compounds to block the replication of poxviruses, such as the emerging infectious disease Monkeypox.
DaVita HealthCare Partners Inc., one of the largest and most innovative health care communities, today announced the company has expanded its office space to include two more floors of the Gates Building, located at 1551 Wewatta Street in Lower Downtown Denver.
Vanda Pharmaceuticals has announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for iloperidone, an investigational atypical antipsychotic for the treatment of schizophrenia.
The proportion of poor adults age 40 and over with diabetes who had their blood sugar, eyes and feet examined at least once a year dropped from 39 percent to 23 percent between 2002 and 2007, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
The European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI) and the Biotechnology and Biological Sciences Research Council (BBSRC) warmly welcome today's announcement from the UK Government of a £75 million commitment from the Department for Business, Innovation and Skills' Large Facilities Capital Fund (LFCF) for the ELIXIR research infrastructure.
› Verified 4 days ago
Dr. Jennifer A Hofstra, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1055 N Curtis Road, Boise, ID 83706 Phone: 757-446-8920 Fax: 757-446-5242 | |
Dr. James Robert Polk, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1055 N Curtis Rd, Boise, ID 83706 Phone: 208-367-3104 | |
Dr. Michael Frederic Krug, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 500 W. Fort St, # 111, Boise, ID 83702 Phone: 208-422-1000 Fax: 208-422-1319 | |
Derrel V Walker, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1055 N Curtis Road, Boise, ID 83706 Phone: 208-367-7350 Fax: 208-367-3951 | |
Dr. Janat E. O'donnell, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 500 W. Fort St., # 111, Boise, ID 83702 Phone: 208-422-1325 Fax: 208-422-1319 | |
Carl L Durning, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 6094 W Emerald St, Boise, ID 83704 Phone: 208-367-6575 Fax: 208-367-6597 | |
Dr. Christopher J Goulet, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6259 W Emerald St, Boise, ID 83704 Phone: 208-489-1900 Fax: 208-375-5286 |